Pancreatoduodenal carcinoma: A clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19‐9
- 20 July 1991
- journal article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 47 (3) , 148-154
- https://doi.org/10.1002/jso.2930470303
Abstract
A total of 304 patients with pancreatoduodenal carcinoma were studied clinicopathologically and immunohistochemically in order to clarify features of carcinoma of four different sites of origin; carcinoma of the ampulla of Vater (Am), the distal common bile duct (DCBD), the head of the pancreas (PH), and the extra‐ampullary duodenum (Du). The mean greatest diameter of 87 PH was 3.5 cm compared with 2.7 cm of 149 Am and 2.7 cm of DCBD. Histopathologically, 40% of Am were papillary adenocarcinoma, while about half of DCBD, PH and Du were tubular adenocarcinoma. PH invaded lymphatic (85%), vascular (62%), and perineural (95%) spaces and metastasized lymph nodes (72%) more frequently than Am (77%, 35%, 24%, 50%), DCBD (47%, 61%, 65%, 45%), and Du (76%, 29%, 35%, 65%), respectively. More than 50% of PH invaded the resected margins, whereas in only 2% of Am, the surgical margins were affected by malignant cells. Immunohistochemically, PH was more frequently positive for both carcinoembryonic antigen (CEA) (98%) and carbohydrate antigen (CA) 19‐9 (91%) than Am (83%, 62%), DCBD (94%, 58%), and Du (56%, 11%), respectively. The stromal staining type of CEA and CA19‐9 was more frequently seen in PH (27%, 44%) than in Am (9%, 31%), DCBD (11%, 8%) and Du (0%, 0%), showing a more dedifferentiated nature of PH. The cumulative 3‐year survival rate of 87 patients with PH (15%) was worse than that of 149 with Am (42%, P < 0.001), of 51 with DCBD (25%) and of 17 with Du (58%, P < 0.001). The survival curve of 87 with PH was worse than that of 51 with DCBD, of 149 with Am (P < 0.001) and of 17 with Du (P < 0.001). Cox regression analysis, using eleven profound prognostic variables, revealed that venous invasion, perineural infiltration, surgical margin, and histopathologic type were profound pronostic factors. Pancreatic carcinoma has a more dedifferentiated histopathologic nature, showing a more aggressive growth and fares worse than Am, DCBD, and Du.Keywords
This publication has 19 references indexed in Scilit:
- Clinical and Pathologic Correlations in Patients With Periampullary TumorsArchives of Surgery, 1990
- Cancer of the extrahepatic bile duct: A clinicopathologic study of immunohistochemistry for CEA, CA19-9, and p21World Journal of Surgery, 1988
- Cystic neoplasms of the pancreasGastroenterology, 1987
- Carcinoma of the ampulla of vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenomaCancer, 1987
- Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancerBritish Journal of Cancer, 1986
- Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreasGastroenterology, 1986
- Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitisBritish Journal of Cancer, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Pancreaticoduodenal ResectionArchives of Surgery, 1973
- Carcinoma of the PancreasSurgical Clinics of North America, 1968